The role of nigrostriatal and striatal cell subtype signaling in behavioral impairments related to schizophrenia
黑质纹状体和纹状体细胞亚型信号传导在精神分裂症相关行为障碍中的作用
基本信息
- 批准号:10751224
- 负责人:
- 金额:$ 4.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2024
- 资助国家:美国
- 起止时间:2024-01-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AcademiaAddressAffectAgonistAmphetaminesAntipsychotic AgentsAutomobile DrivingBasal GangliaBehaviorBehavioralBrainCapsaicinCationsCellsCodeCognitionCognitiveCorpus striatum structureData AnalysesDedicationsDelusionsDiseaseDopamineDopamine AntagonistsDopamine D1 ReceptorDopamine D2 ReceptorDorsalEducational process of instructingElectrophysiology (science)EnsureEnvironmentEtiologyFellowshipFiberFluorescenceFunctional disorderGeneticGoalsGrantHallucinationsHyperactivityImageImpaired cognitionKnockout MiceKnowledgeLinkLocomotionManuscriptsMeasuresMemory impairmentMental disordersMentorshipMethodsMicroscopeMusNational Research Service AwardsNeurobehavioral ManifestationsNeuronal DysfunctionNeuronsOutputPathway interactionsPatientsPatternPhotometryProcessProxyPsychosesPsychotic DisordersReceptor SignalingResearchResistanceRoleSchizophreniaScienceShort-Term MemorySignal TransductionSocial FunctioningSocial InteractionSubstantia nigra structureSymptomsTRPV1 geneTechniquesTestingTherapeuticThinkingTrainingWithdrawalWorkWritingbehavioral constructbehavioral impairmentcognitive functiondesigner receptors exclusively activated by designer drugsdopaminergic neuronexperimental studygenetic manipulationimprovedin vivoin vivo imagingneuralneural circuitneuroimagingnigrostriatal pathwaynovel therapeutic interventionreceptorreceptor expressionselective expressionsocialsocial deficitssuccesstransmission process
项目摘要
Project Summary/Abstract
In psychotic disorders, excess nigrostriatal (NS) dopamine signaling is linked to hallucinations, delusions, and
disorganized thought—positive symptoms that respond to antipsychotic drugs. By contrast, the prevalent
negative and cognitive symptoms in these disorders are largely unresponsive to treatment. Antipsychotic drugs
are thought to work by blocking D2 dopamine receptors (D2Rs), which are highly expressed in the striatum. This
observation and the fact that increasing brain-wide dopamine (via amphetamine treatment) improves cognition
fueled the dogma that excess dopamine is not involved in cognitive and negative symptoms. However, in patients
with schizophrenia, dopamine is selectively increased in the striatum (not throughout the brain). Moreover, the
striatum also expresses D1 dopamine receptors (D1Rs), which are not targeted by current antipsychotics.
Therefore, dopamine may contribute to negative and cognitive symptoms through striatal D1R signaling, but this
idea has never been directly tested. The goal of the proposed research is to determine whether striatal D1R-
and D2R-expressing spiny projection neurons (SPNs) differentially contribute to dopamine-driven deficits in
social and cognitive function. To do this, I developed an approach to mimic the pathway-specific excess in
dopamine observed in schizophrenia by selectively expressing the excitatory cation channel TRPV1 in SNc
dopamine neurons of Trpv1 knockout mice. Systemically treating these mice with the TRPV1 agonist capsaicin
increases dopamine release in the dorsal striatum but not prefrontal cortex (PFC) as measured by dLight
fluorescence using in vivo fiber photometry. Selectively driving NS dopamine transmission in this way increases
locomotion, but also disrupts social interaction and working memory, behavioral proxies for negative and
cognitive symptoms. Here I propose to expand on these findings with the following specific aims:
(1) In Aim 1, I will use the TRPV1-based approach with miniature microscopes to image Ca2+ activity in
D1- or D2-SPNs under normal and hyperdopaminergic conditions to determine how altered activity in each SPN
type contributes to deficits in social and cognitive behavior. (2) In Aim 2, I will use the TRPV1-based approach
with chemogenetic manipulations of D1R- or D2R-expressing SPNs to causally link their activity to specific
changes in behavior caused by selectively driving striatal dopamine release. By defining the roles of striatal D1-
and D2-SPNs in dopamine-driven changes in behavioral constructs related to the symptoms of schizophrenia,
my experiments have the potential to identify novel therapeutic strategies for psychosis that more
comprehensively address its symptoms. Under this fellowship, I plan to receive training in in vivo imaging and
electrophysiology recording techniques, coding and data analysis, grant and manuscript writing, teaching and
mentorship, and further knowledge of basal ganglia-related dysfunction and psychiatric disease. My training
goals, dedication to progressing science research and diversity in academia, strong mentorship team, and the
vibrant academic environment at Northwestern ensure I will reach success as an NRSA fellow.
项目摘要/摘要
在精神障碍中,过量的黑质纹状体(NS)多巴胺信号与幻觉、妄想和
对抗精神病药物有反应的杂乱无章的阳性思维症状。相比之下,盛行的
这些疾病中的阴性和认知症状在很大程度上对治疗没有反应。抗精神病药物
被认为是通过阻断D2多巴胺受体(D2Rs)起作用的,D2Rs在纹状体中高度表达。这
增加全脑多巴胺(通过苯丙胺治疗)改善认知的观察和事实
助长了过量的多巴胺与认知和消极症状无关的教条。然而,在患者中
对于精神分裂症,多巴胺在纹状体(而不是整个大脑)选择性地增加。此外,
纹状体也表达D1多巴胺受体(D1Rs),这是目前的抗精神病药物不针对的。
因此,多巴胺可能通过纹状体D1R信号导致阴性和认知症状,但这
这个想法从未被直接测试过。这项拟议研究的目标是确定纹状体D1R-
和D2R表达的棘突投射神经元(SPN)对多巴胺驱动的脑缺血有不同的作用
社会功能和认知功能。为了做到这一点,我开发了一种方法来模拟
选择性表达兴奋性阳离子通道TRPV1在精神分裂症中观察到的多巴胺
TRPV1基因敲除小鼠的多巴胺神经元。用TRPV1激动剂辣椒素系统治疗这些小鼠
增加背侧纹状体的多巴胺释放,但不增加前额叶皮质(PFC)
荧光法采用体内纤维光度法。以这种方式选择性地驱动NS多巴胺传递增加
运动,但也扰乱了社会互动和工作记忆,这是负面和
认知症状。在这里,我建议以以下具体目标来扩大这些调查结果:
(1)在目标1中,我将使用基于TRPV1的方法和微型显微镜来成像
在正常和高多巴胺能条件下测定D_1或D_2-SPN的活性变化
类型会导致社交和认知行为的缺陷。(2)在目标2中,我将使用基于TRPV1的方法
通过对表达D1R或D2R的SPN进行化学遗传操作,将其活性与特定的
选择性地驱动纹状体多巴胺释放引起的行为变化。通过定义纹状体D1的角色-
和D2-SPN在多巴胺驱动的与精神分裂症症状相关的行为结构的变化中,
我的实验有可能发现精神病的新治疗策略
全面对症下药。根据这一奖学金,我计划接受体内成像和
电生理记录技术、编码和数据分析、助学金和手稿写作、教学和
指导,以及对基底节相关功能障碍和精神疾病的进一步了解。我的训练
目标,致力于科学研究的进步和学术界的多样性,强大的导师团队,以及
西北大学充满活力的学术环境确保了我作为一名NRSA研究员取得成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicolette A Moya其他文献
Nicolette A Moya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 4.29万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 4.29万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 4.29万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 4.29万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 4.29万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 4.29万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 4.29万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 4.29万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 4.29万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 4.29万 - 项目类别:
Research Grant